Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Heterozygous FUT1 mutations causing a para-bombay phenotype
 
  • Details
Options

Heterozygous FUT1 mutations causing a para-bombay phenotype

Journal
Clinical Laboratory
Date Issued
2018-01-01
Author(s)
TAO-CHIEH YANG  
DOI
10.7754/Clin.Lab.2018.180428
URI
https://www.scopus.com/pages/publications/85055075636
https://scholars.csmu.edu.tw/handle/123456789/27535
Abstract
Background: To study a case of para-Bombay phenotype caused by compound heterozygous mutation of the FUT1 gene. Methods: We performed an agglutination examination to anti-H serum. Secretor status was determined in order to assess the presence of soluble blood group substances. Genotyping of ABO and FUT1 genes were also performed. Results: Our results showed the presence of A and H antigens in the saliva. Based on these results, the patient in the present case was diagnosed to have a para-Bombay A phenotype. Direct DNA sequencing of the patient’s ABO gene indicated A1v/O1vgenotype. FUT1 gene sequence analysis revealed that the patient harbored the compound heterozygous mutations c.881_882delTT (p.Phe294Cysfs) and c.551_552delAG (p.Glu184Valfs). Conclusions: In summary, our findings support that the occurrence of a heterozygous mutation in FUT1, 547-delAG/880delTT, is the most common mutation in Taiwanese.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback